{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/328184977"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "r continues. ???We feel the ability of EpiScreen to recognize these problematic antibodies early in their development is an important tool for insuring highly successful biologics." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "genengnews.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/354405602"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/328184977"] } } }
